| Q35069345 | Attenuation of eph receptor kinase activation in cancer cells by coexpressed ephrin ligands |
| Q34029227 | Decreased expression of receptor tyrosine kinase of EphB1 protein in renal cell carcinomas |
| Q38109928 | Druggable orthosteric and allosteric hot spots to target protein-protein interactions. |
| Q36727369 | Effects of cancer-associated EPHA3 mutations on lung cancer. |
| Q37384464 | Elevation of receptor tyrosine kinase EphA2 mediates resistance to trastuzumab therapy. |
| Q38997973 | Eph Receptor Tyrosine Kinases in Tumor Immunity |
| Q41784769 | Eph receptor and mTOR pathway crosstalk: implications for cancer |
| Q21328694 | Eph receptors and ephrin ligands: important players in angiogenesis and tumor angiogenesis |
| Q37045576 | EphA4-deleted microenvironment regulates cancer development and leukemoid reaction of the isografted 4T1 murine breast cancer via reduction of an IGF1 signal |
| Q39833824 | Ephrin-independent regulation of cell substrate adhesion by the EphB4 receptor |
| Q34845606 | EphrinA2 regulates clathrin mediated KSHV endocytosis in fibroblast cells by coordinating integrin-associated signaling and c-Cbl directed polyubiquitination |
| Q39429505 | Evidence for a dual function of EphB4 as tumor promoter and suppressor regulated by the absence or presence of the ephrin-B2 ligand |
| Q36375472 | Expression of EphA2 protein is positively associated with age, tumor size and Fuhrman nuclear grade in clear cell renal cell carcinomas |
| Q44108600 | High expression of EphA1 in esophageal squamous cell carcinoma is associated with lymph node metastasis and advanced disease |
| Q45954932 | Humanized anti-EphB4 antibodies for the treatment of carcinomas and vasculogenesis-related diseases. |
| Q35983048 | Kaposi's sarcoma-associated herpesvirus interacts with EphrinA2 receptor to amplify signaling essential for productive infection |
| Q37312725 | Ligand-dependent EphB1 signaling suppresses glioma invasion and correlates with patient survival |
| Q94526762 | Ligand-independent EphB1 signaling mediates TGF-β-activated CDH2 and promotes lung cancer cell invasion and migration |
| Q30474770 | Molecular ultrasound assessment of tumor angiogenesis |
| Q89178806 | NVP-BHG712: Effects of Regioisomers on the Affinity and Selectivity toward the EPHrin Family |
| Q45989150 | Over-expression of EphB3 enhances cell-cell contacts and suppresses tumor growth in HT-29 human colon cancer cells. |
| Q92856282 | Patterns of Mutation Enrichment in Metastatic Triple-Negative Breast Cancer |
| Q34364217 | Peritumoral small ephrinA5 isoform level predicts the postoperative survival in hepatocellular carcinoma |
| Q34150471 | Promiscuous and specific recognition among ephrins and Eph receptors |
| Q26860972 | Role of Eph/ephrin tyrosine kinase in malignant glioma |
| Q37584993 | Roles of EphA2 in Development and Disease |
| Q58780428 | Somatic genome alterations in relation to age in lung squamous cell carcinoma |
| Q54979291 | Specific Eph receptor-cytoplasmic effector signaling mediated by SAM-SAM domain interactions. |
| Q34926887 | Structural Analysis of the Binding of Type I, I1/2, and II Inhibitors to Eph Tyrosine Kinases |
| Q39672762 | Structure-activity relationship analysis of peptides targeting the EphA2 receptor |
| Q28507101 | The SAM domains of Anks family proteins are critically involved in modulating the degradation of EphA receptors |
| Q35773939 | The receptor tyrosine kinase EphA2 is a direct target gene of hypermethylated in cancer 1 (HIC1). |
| Q38150596 | The role of EPH receptors in cancer-related epithelial-mesenchymal transition |
| Q37629840 | Tie2 and Eph receptor tyrosine kinase activation and signaling |
| Q34437633 | VAMP-associated protein B (VAPB) promotes breast tumor growth by modulation of Akt activity |